Neurostimulation Devices Market Consumption by Type, Application And Sales 2017 Analysis And Forecasts To 2022
Feb 10, 2017
Wiseguyreports.Com Adds “Neurostimulation Devices -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2022” To Its Research Database.
Pune, India - February 10, 2017 /MarketersMedia/ —
Neurostimulation Devices Industry
Description
This report studies sales (consumption) of Neurostimulation Devices in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Medtronic
Boston Scientific
St.Jude Medical
LivaNova (Cyberonics)
Nevro
Inspire Medical Systems
NeuroPace
Autonomic Technologies
NeuroSigma
Neuros Medical
ImThera Medical
Synapse Biomedical
Atrotech
ElectroCore
SPR Therapeutics
NeuroMetrix
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/901614-global-neurostimulation-devices-sales-market-report-2017
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Neurostimulation Devices in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Spinal Cord Stimulation (SCS)
Gastric Electric Stimulation (GES)
Deep Brain Stimulation (DBS)
Sacral Nerve Stimulation (SNS)
Vagus Nerve Stimulation (VNS)
Split by applications, this report focuses on sales, market share and growth rate of Neurostimulation Devices in each application, can be divided into
Pain Management
Parkinson’s Disease
Urinary and Fecal Incontinence
Epilepsy
Gastroparesis
Leave a Query @ https://www.wiseguyreports.com/enquiry/901614-global-neurostimulation-devices-sales-market-report-2017
Table of Contents
Global Neurostimulation Devices Sales Market Report 2017
1 Neurostimulation Devices Overview
1.1 Product Overview and Scope of Neurostimulation Devices
1.2 Classification of Neurostimulation Devices
1.2.1 Spinal Cord Stimulation (SCS)
1.2.2 Gastric Electric Stimulation (GES)
1.2.3 Deep Brain Stimulation (DBS)
1.2.4 Sacral Nerve Stimulation (SNS)
1.2.5 Vagus Nerve Stimulation (VNS)
1.3 Application of Neurostimulation Devices
1.3.1 Pain Management
1.3.2 Parkinson’s Disease
1.3.3 Urinary and Fecal Incontinence
1.3.4 Epilepsy
1.3.5 Gastroparesis
1.4 Neurostimulation Devices Market by Regions
1.4.1 United States Status and Prospect (2011-2021)
1.4.2 China Status and Prospect (2011-2021)
1.4.3 Europe Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Neurostimulation Devices (2011-2021)
1.5.1 Global Neurostimulation Devices Sales and Growth Rate (2011-2021)
1.5.2 Global Neurostimulation Devices Revenue and Growth Rate (2011-2021)
....
9 Global Neurostimulation Devices Manufacturers Analysis
9.1 Medtronic
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Neurostimulation Devices Product Type, Application and Specification
9.1.2.1 Spinal Cord Stimulation (SCS)
9.1.2.2 Gastric Electric Stimulation (GES)
9.1.3 Medtronic Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
9.1.4 Main Business/Business Overview
9.2 Boston Scientific
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Neurostimulation Devices Product Type, Application and Specification
9.2.2.1 Spinal Cord Stimulation (SCS)
9.2.2.2 Gastric Electric Stimulation (GES)
9.2.3 Boston Scientific Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
9.2.4 Main Business/Business Overview
9.3 St.Jude Medical
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Neurostimulation Devices Product Type, Application and Specification
9.3.2.1 Spinal Cord Stimulation (SCS)
9.3.2.2 Gastric Electric Stimulation (GES)
9.3.3 St.Jude Medical Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
9.3.4 Main Business/Business Overview
9.4 LivaNova (Cyberonics)
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Neurostimulation Devices Product Type, Application and Specification
9.4.2.1 Spinal Cord Stimulation (SCS)
9.4.2.2 Gastric Electric Stimulation (GES)
9.4.3 LivaNova (Cyberonics) Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
9.4.4 Main Business/Business Overview
9.5 Nevro
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Neurostimulation Devices Product Type, Application and Specification
9.5.2.1 Spinal Cord Stimulation (SCS)
9.5.2.2 Gastric Electric Stimulation (GES)
9.5.3 Nevro Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
9.5.4 Main Business/Business Overview
9.6 Inspire Medical Systems
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Neurostimulation Devices Product Type, Application and Specification
9.6.2.1 Spinal Cord Stimulation (SCS)
9.6.2.2 Gastric Electric Stimulation (GES)
9.6.3 Inspire Medical Systems Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
9.6.4 Main Business/Business Overview
9.7 NeuroPace
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Neurostimulation Devices Product Type, Application and Specification
9.7.2.1 Spinal Cord Stimulation (SCS)
9.7.2.2 Gastric Electric Stimulation (GES)
9.7.3 NeuroPace Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
9.7.4 Main Business/Business Overview
9.8 Autonomic Technologies
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Neurostimulation Devices Product Type, Application and Specification
9.8.2.1 Spinal Cord Stimulation (SCS)
9.8.2.2 Gastric Electric Stimulation (GES)
9.8.3 Autonomic Technologies Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
9.8.4 Main Business/Business Overview
9.9 NeuroSigma
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Neurostimulation Devices Product Type, Application and Specification
9.9.2.1 Spinal Cord Stimulation (SCS)
9.9.2.2 Gastric Electric Stimulation (GES)
9.9.3 NeuroSigma Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
9.9.4 Main Business/Business Overview
9.10 Neuros Medical
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Neurostimulation Devices Product Type, Application and Specification
9.10.2.1 Spinal Cord Stimulation (SCS)
9.10.2.2 Gastric Electric Stimulation (GES)
9.10.3 Neuros Medical Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
9.10.4 Main Business/Business Overview
9.11 ImThera Medical
9.12 Synapse Biomedical
9.13 Atrotech
9.14 ElectroCore
9.15 SPR Therapeutics
9.16 NeuroMetrix
Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=901614
Continued...
Contact Us: [email protected] Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK)
Contact Info:
Name: NORAH TRENT
Email: [email protected]
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Pune 411028 , Maharashtra, India
Phone: +1-646-845-9349 / +44 208 133 9349
For more information, please visit https://www.wiseguyreports.com/sample-request/901614-global-neurostimulation-devices-sales-market-report-2017
Source: MarketersMedia
Release ID: 168966
Taiwan and Singapore back NSV’s US$53M bet on Asia’s biotech pipeline
Raising a debut fund in 2026 is hard. Raising one for biotech, a sector investors have spent four years avoiding, is harder still. NeoSci Ventures (NSV) says it has done it anyway. The Singapore-, Taiwan- and US-based venture builder has announced a first close of SGD70 million (US$53 million) for its inaugural institutional fund. The […] The post Taiwan and Singapore back NSV’s US$53M bet on Asia’s biotech pipeline appeared first on e27.
Indonesia urgently needs an allergy data centre to support national food security
Food allergy in Indonesia is a real concern, and we cannot ignore it. According to CNN Indonesia, about 1.7 million children in Indonesia have allergies, and cow’s milk is one of the triggers. This number was shared by Ray Wagiu Basrowi, a doctor and researcher, during World Allergy Week 2026 with Sarihusada in Jakarta on […] The post Indonesia urgently needs an allergy data centre to support national food security appeared first on e27.
Vietnam’s climate-tech has a missing middle, and women founders are falling into it
In Vietnam’s climate-tech scene, a founder can win a grant and, with luck, eventually land a cheque worth several million dollars. What she is increasingly unlikely to find is anything in between. Recorded climate tech funding in Vietnam fell 52 per cent in 2025 to US$49.86 million across 33 transactions, down from US$104.20 million across […] The post Vietnam’s climate-tech has a missing middle, and women founders are falling into it appeared first on e27.
Singapore and Romania don’t need another MOU. They need first customers
On a weekday afternoon in late October, a group of Romanian founders pitched to a Singapore audience over Teams. One of them signed off with a plain request. He would be in Singapore the week of the Singapore Fintech Festival, he said, and he’d love an introduction to anyone who runs compliance or risk at […] The post Singapore and Romania don’t need another MOU. They need first customers appeared first on e27.
Are AI fears genuine? Why we should demand evidence, not alarm
Over the past couple of months, I’ve come across several perspectives from AI founders that have made me question whether the fears surrounding AI are genuine concerns or narratives being shaped to serve their own interests. Recent comments by some of the biggest names in the technology industry about AI should be judged by facts […] The post Are AI fears genuine? Why we should demand evidence, not alarm appeared first on e27.
Apple could launch up to three new iPads in the first half of 2027
Readers looking to get a new tablet could be spoilt for choice next year.
HKSTP drives Hong Kong mobility innovators to test and scale in Singapore
Ask a Hong Kong engineer why their product deserves a place abroad and you will often hear the same answer: the city is the hardest test bed they know. Towers scramble satellite signals, space is scarce, labour is expensive and safety rules leave little room for error. Survive that, the argument goes, and most other […] The post HKSTP drives Hong Kong mobility innovators to test and scale in Singapore appeared first on e27.
In Southeast Asia, winning at home may no longer be enough
For years, Southeast Asian founders were told to win their home market before expanding abroad. Prove the product, build the team, establish revenue, then move into neighbouring countries. That advice still makes sense. But for startups seeking institutional venture capital, it is becoming less sufficient. Investors are paying closer attention to the limits of domestic […] The post In Southeast Asia, winning at home may no longer be enough appeared first on e27.
Garmin’s new fenix 9 and 9 Pro command a high price fit for premium smartwatches
But surprisingly, they’re cheaper than their predecessors at launch.
Magic: The Gathering’s Star Trek Commander Decks
MANILA, Philippines – The Final Frontier is making its way to the Commander table as Star Trek joins Magic: The Gathering (MTG) with four new preconstructed decks set to release on November 13, 2026. As the final major release in MTG’s 2026 lineup, the Star Trek collaboration brings some of the franchise’s most recognizable characters,
Redefining gamers and rethinking gaming with Ria Lu
An interview with Ria Lu and an analysis on the perception of video games and young gamers in the Philippines. MANILA, Philippines – There’s been so much attention on video games and heat on the Philippine video game industry because of the spate of school shootings of the last couple months. These events have been
China’s EDA champion buys start-up to address weak link, support Huawei’s Tau Scaling Law
Empyrean Technology, China’s top provider of electronic design automation (EDA) tools, plans to acquire a majority stake in a domestic start-up, reinforcing Beijing’s drive for tech self-sufficiency and bolstering support for Huawei Technologies’ semiconductor ambitions. The Beijing-based firm said in a Shenzhen Stock Exchange filing on Sunday that it would acquire a 50.38 per cent stake in Easy-Logic Technology for 218.8 million yuan (US$33 million). Once completed, the start-up would be...
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.